Miki M, Inubushi S, Han Q, Inoue S, et al. Efficacy of Methionine Restriction and the PARP-inhibitor Olaparib and Their
Combination on BRCA1 Mutant and Wild-type Triple-negative Breast Cancer Cell
Lines. Anticancer Res 2025;45:1367-1372.
PMID: 40155022
|